AGNIESZKA ZAPOROWSKA: Open Payments
NPI 1760069736 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 33 payments from 12 companies in 2025. Trend: 2023 $307 · 2024 $1,177 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $316 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| Teva Pharmaceuticals USA, Inc. | 4 | $95 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Laborie Medical Technologies Corp. | 2 | $45 |
| Noven Therapeutics, LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Alkermes, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, REXULTI, HETLIOZ, Xelstrym, Auvelity, Optilume BPH Drug Coated Balloon Catheter.
Industry payments across FL — which companies pay providers there.
